Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study

Taku Fujimura, Yota Sato, Kayo Tanita, +17

Oncotarget

<scp>HLA</scp>‐<scp>DRB</scp>1*04:05 in two cases of Vogt–Koyanagi–Harada disease‐like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapy

Taku Fujimura, Yumi Kambayashi, Kayo Tanita, +7

The Journal of Dermatology

OncologyUveitis DevelopingMedicineMelanomaImmunology +10

Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell Lymphoma

Kayo Tanita, Taku Fujimura, Yota Sato, +9

Frontiers in Oncology

Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma

Taku Fujimura, Yota Sato, Kayo Tanita, +19

Frontiers in Oncology

Advanced Cutaneous MelanomaMedicineMelanomaImmunologySoluble Cd163 May +11

Association of Baseline Serum Levels of CXCL5 With the Efficacy of Nivolumab in Advanced Melanoma

Taku Fujimura, Yota Sato, Kayo Tanita, +17

Frontiers in Medicine

Advanced Cutaneous MelanomaTumor BiologyCancer ImmunosurveillanceMedicineMelanoma +12

Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages

Taku Fujimura, Aya Kakizaki, Yumi Kambayashi, +5

Experimental Dermatology

<i>Malassezia</i>‐derived aryl hydrocarbon receptor ligands enhance the CCL20/Th17/soluble CD163 pathogenic axis in extra‐mammary Paget's disease

Yota Sato, Taku Fujimura, Kayo Tanita, +7

Experimental Dermatology

Microbial PathogensImmunodeficienciesImmune RegulationImmunologyPathology +23

Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab

Kayo Tanita, Taku Fujimura, Yumi Kambayashi, +4

Case Reports in Oncology

Cancer ImmunosurveillanceAutoimmune DiseaseMelanomaImmunologyPathology +12

Minocycline decreases Th2 chemokines from M2 macrophages: Possible mechanisms for the suppression of bullous pemphigoid by traditional bullous disease drugs

Kayo Tanita, Taku Fujimura, Yota Sato, +2

Experimental Dermatology

A novel technique to diagnose non‐melanoma skin cancer by thermal conductivity measurements: Correlations with cancer stromal factors

Taku Fujimura, Takahiro Okabe, Kayo Tanita, +5

Experimental Dermatology

Cancer Stromal FactorsEngineeringPathologyDermatologyInvasive Empd +20